Usana Health Sciences
USNA
190 hedge funds and large institutions have $1.46B invested in Usana Health Sciences in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 84 reducing their positions, and 29 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.33% less ownership
Funds ownership: 55.31% → 51.98% (-3.3%)
4% less funds holding
Funds holding: 197 → 190 (-7)
10% less capital invested
Capital invested by funds: $1.62B → $1.46B (-$160M)
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
37% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 84
89% less call options, than puts
Call options by funds: $294K | Put options by funds: $2.65M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2M |
| 2 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$5.94M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.91M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$3.99M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$25.1M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$22.2M |
| 3 |
Man Group
London,
United Kingdom
|
-$10.6M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.72M |
| 5 |
SG Americas Securities
New York
|
-$9.03M |
USNA Hedge Fund Activity: Q4 2018 in Review
190 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2018, worth a combined $1.46B — down 9.9% from $1.62B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of USNA and 22 opened new positions — a net loss of 7 holders — while 84 trimmed existing stakes and 53 added.
The largest buyer was Vanguard Group, adding an estimated $12.2M. The largest seller was Renaissance Technologies, cutting an estimated $25.1M.
- 190 institutional investors held Usana Health Sciences (USNA) as of Q4 2018, down from 197 in Q3 2018.
- Funds reported $1.46B of Usana Health Sciences stock for Q4 2018, down 9.9% quarter-over-quarter.
- 22 funds opened new Usana Health Sciences positions in Q4 2018 and 29 closed out, a net change of -7 holders.
- The largest Usana Health Sciences buyer in Q4 2018 was Vanguard Group, an estimated $12.2M added.
- The largest Usana Health Sciences seller in Q4 2018 was Renaissance Technologies, an estimated $25.1M sold.
Based on aggregated 13F filings for Q4 2018.